The Innovative Medicines Initiative: A European Response to the Innovation Challenge
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Innovative Medicines Initiative: A European Response to the Innovation Challenge
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 91, Issue 3, Pages 418-425
Publisher
Springer Nature
Online
2012-02-09
DOI
10.1038/clpt.2011.321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European Perspective on Risk Management and Drug Safety
- (2011) J Raine et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A generic operational strategy to qualify translational safety biomarkers
- (2011) Katja Matheis et al. DRUG DISCOVERY TODAY
- A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity
- (2011) Cristian Obiol-Pardo et al. Journal of Chemical Information and Modeling
- A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion
- (2011) Philippe Ravassard et al. JOURNAL OF CLINICAL INVESTIGATION
- Shaping the future of safer innovative drugs in Europe
- (2011) Jordi Mestres et al. NATURE BIOTECHNOLOGY
- Time to 'walk the walk' about industry ties to enhance health
- (2011) Thomas P Stossel et al. NATURE MEDICINE
- Enhancing ties between academia and industry to improve health
- (2011) S Claiborne Johnston et al. NATURE MEDICINE
- Reflections on the Innovative Medicines Initiative
- (2011) Michel Goldman NATURE REVIEWS DRUG DISCOVERY
- Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
- (2011) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- Biomedical Research and Health Advances
- (2011) Hamilton Moses et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of Novel Combination Therapies
- (2011) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice
- (2011) Harri Lempiäinen et al. PLoS One
- CXCL5 Mediates UVB Irradiation-Induced Pain
- (2011) J. M. Dawes et al. Science Translational Medicine
- Defining Success for Translational Research Organizations
- (2011) R. Pozen et al. Science Translational Medicine
- How to Revive Breakthrough Innovation in the Pharmaceutical Industry
- (2011) B. H. Munos et al. Science Translational Medicine
- "Creating Hope" and Other Incentives for Drug Development for Children
- (2011) E. Connor et al. Science Translational Medicine
- Power to the People: Participant Ownership of Clinical Trial Data
- (2011) S. F. Terry et al. Science Translational Medicine
- The Precompetitive Space: Time to Move the Yardsticks
- (2011) T. Norman et al. Science Translational Medicine
- Commercialization and Collaboration: Competing Policies in Publicly Funded Stem Cell Research?
- (2010) Tania Bubela et al. Cell Stem Cell
- An Integrative Systems Biology Approach to Understanding Pulmonary Diseases
- (2010) Charles Auffray et al. CHEST
- The Biomarkers Consortium: Practice and Pitfalls of Open-Source Precompetitive Collaboration
- (2010) J A Wagner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Regulatory Science: What It Is and Why We Need It
- (2010) G A FitzGerald CLINICAL PHARMACOLOGY & THERAPEUTICS
- Can Open-Source Drug R&D Repower Pharmaceutical Innovation?
- (2010) B Munos CLINICAL PHARMACOLOGY & THERAPEUTICS
- Precompetitive Research: A New Prescription for Drug Development?
- (2010) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Critical Path Institute’s Approach to Precompetitive Sharing and Advancing Regulatory Science
- (2010) R L Woosley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A flexible blueprint for the future of drug development
- (2010) Richard Barker LANCET
- Schizophrenia: The drug deadlock
- (2010) Alison Abbott NATURE
- Pharma embraces open source models
- (2010) Stephen Strauss NATURE BIOTECHNOLOGY
- Mechanism matters
- (2010) NATURE MEDICINE
- The importance of new companies for drug discovery: origins of a decade of new drugs
- (2010) Robert Kneller NATURE REVIEWS DRUG DISCOVERY
- The Missing Voice of Patients in Drug-Safety Reporting
- (2010) Ethan Basch NEW ENGLAND JOURNAL OF MEDICINE
- Network Dynamics to Evaluate Performance of an Academic Institution
- (2010) M. E. Hughes et al. Science Translational Medicine
- Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)
- (2010) E. H. Bel et al. THORAX
- Translational Toxicology and the Work of the Predictive Safety Testing Consortium
- (2009) WB Mattes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Open innovation networks between academia and industry: an imperative for breakthrough therapies
- (2009) Teri Melese et al. NATURE MEDICINE
- Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery
- (2009) Michael R. Barnes et al. NATURE REVIEWS DRUG DISCOVERY
- The FDA Critical Path Initiative and Its Influence on New Drug Development
- (2008) Janet Woodcock et al. Annual Review of Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More